Literature DB >> 1699703

Application of protein A-rosette assay for screening of monoclonal antibodies to human complement regulatory proteins.

T Seya1, T Hara, A Uenaka, E Nakayama, H Akedo.   

Abstract

Mice were immunized with purified membrane cofactor protein (MCP) and its monoclonal antibodies were screened by protein A(PA)-rosette assay. In this assay, the culture supernatants of hybridoma cells were layered over fixed MCP-bearing cells, and after washing, PA-coated sheep erythrocytes were applied as an indicator to these MCP-bearing cells. No purified antigen was therefore required throughout the screening. More than 300 of the supernatants harvested were successfully examined within 6 h. Each resultant antibody consisted of a single subclass of IgG, and reacted only with MCP in both transblotted and surface-labeled materials. The sensitivity of this assay was then assessed with these purified antibodies. As little as 0.5 micrograms of IgG1 or 0.01 micrograms of IgG2a was found to be detectable with more than 30% rosette formation. There were variations among cell lines in the sensitivity to the PA-rosette assay and the sensitivity did not correlate with the quantity of MCP surface expression in any of the cell lines. K562 gave the lowest background (nonspecific rosette formation) and the best specificity for anti-MCP of the 20 MCP-positive cell lines tested. Cell lines suitable for the detection of monoclonal anti-decay-accelerating factor and anti-C3b/C4b receptor were also examined and CCRF-SB and HSB2, and peripheral blood granulocytes, were found to be proper cell lines for screening the decay-accelerating factor and C3b/C4b receptor, respectively. Clones for anti C3b/C4b receptor were successfully obtained using granulocytes by the PA-rosette assay. This method needs no purified antigen and facilitates the rapid screening and purification of positive clones against cell-surface complement regulatory proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699703     DOI: 10.1159/000463132

Source DB:  PubMed          Journal:  Complement Inflamm        ISSN: 1012-8204


  7 in total

1.  Human complement regulatory proteins expressed on mouse A9 cells containing a human chromosome 1.

Authors:  T Seya; M Okada; T Hara; M Matsumoto; S Miyagawa; M Oshimura
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

2.  Engineering of recombinant soluble CD46: an inhibitor of complement activation.

Authors:  D Christiansen; J Milland; B R Thorley; I F McKenzie; P L Mottram; L J Purcell; B E Loveland
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

3.  Identification and quantification of complement regulator CD46 on normal human tissues.

Authors:  R W Johnstone; B E Loveland; I F McKenzie
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

4.  Antibody-independent classical complement pathway activation and homologous C3 deposition in xeroderma pigmentosum cell lines.

Authors:  M Kurita; M Matsumoto; S Tsuji; M Kawakami; Y Suzuki; H Hayashi; K Toyoshima; T Seya
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

5.  Soluble forms of membrane cofactor protein (CD46, MCP) are present in plasma, tears, and seminal fluid in normal subjects.

Authors:  T Hara; S Kuriyama; H Kiyohara; Y Nagase; M Matsumoto; T Seya
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

6.  Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46).

Authors:  T Seya; T Hara; M Matsumoto; Y Sugita; H Akedo
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

7.  Purification and characterization of a human membrane protein that activates the alternative complement pathway and allows the deposition of homologous complement C3.

Authors:  M Matsumoto; F Yamashita; K Iida; M Tomita; T Seya
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.